» Articles » PMID: 38191908

Time of Day Bias for Biological Sampling in Studies of Mammary Cancer

Overview
Journal Sci Rep
Specialty Science
Date 2024 Jan 9
PMID 38191908
Authors
Affiliations
Soon will be listed here.
Abstract

Despite its demonstrated biological significance, time of day is a broadly overlooked biological variable in preclinical and clinical studies. How time of day affects the influence of peripheral tumors on central (brain) function remains unspecified. Thus, we tested the hypothesis that peripheral mammary cancer tumors alter the transcriptome of immune responses in the brain and that these responses vary based on time of day; we predicted that time of day sampling bias would alter the interpretation of the results. Brain tissues collected at mid dark and mid light from mammary tumor-bearing and vehicle injected mice were analyzed using the Nanostring nCounter immune panel. Peripheral mammary tumors significantly affected expression within the brain of over 100 unique genes of the 770 represented in the panel, and fewer than 25% of these genes were affected similarly across the day. Indeed, between 65 and 75% of GO biological processes represented by the differentially expressed genes were dependent upon time of day of sampling. The implications of time-of-day sampling bias in interpretation of research studies cannot be understated. We encourage considering time of day as a significant biological variable in studies and to appropriately control for it and clearly report time of day in findings.

Citing Articles

Light Cycle Phase Effects on Behavioral Responses to Stress Exposure in Rats.

Brown C, Borrell A, DeMar J, Almarode C, Naderi A, Han A J Am Assoc Lab Anim Sci. 2025; 64(1):64-75.

PMID: 40035271 PMC: 11808373. DOI: 10.30802/AALAS-JAALAS-24-103.

References
1.
Sullivan K, Bever S, McKim D, Godbout J, Sheridan J, Obrietan K . Mammary tumors compromise time-of-day differences in hypothalamic gene expression and circadian behavior and physiology in mice. Brain Behav Immun. 2019; 80:805-817. PMC: 6664435. DOI: 10.1016/j.bbi.2019.05.028. View

2.
Borniger J, Walker Ii W, Surbhi , Emmer K, Zhang N, Zalenski A . A Role for Hypocretin/Orexin in Metabolic and Sleep Abnormalities in a Mouse Model of Non-metastatic Breast Cancer. Cell Metab. 2018; 28(1):118-129.e5. PMC: 6031468. DOI: 10.1016/j.cmet.2018.04.021. View

3.
Heppner G, Miller F, Shekhar P . Nontransgenic models of breast cancer. Breast Cancer Res. 2001; 2(5):331-4. PMC: 138654. DOI: 10.1186/bcr77. View

4.
Lange M, Joly F, Vardy J, Ahles T, Dubois M, Tron L . Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Ann Oncol. 2019; 30(12):1925-1940. PMC: 8109411. DOI: 10.1093/annonc/mdz410. View

5.
Howell D, Oliver T, Keller-Olaman S, Davidson J, Garland S, Samuels C . Sleep disturbance in adults with cancer: a systematic review of evidence for best practices in assessment and management for clinical practice. Ann Oncol. 2013; 25(4):791-800. DOI: 10.1093/annonc/mdt506. View